Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Norvège (1)
Education (awareness, health promotion)
Across all conditions/Other (1)
Research Institution (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Shared purpose
Clinical study phase III